Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07027514 |
| Title | A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Ankyra Therapeutics, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Community Health Network | RECRUITING | Indianapolis | Indiana | 46256 | United States | Details |
| Barbara Ann Karmanos Cancer Hospital | RECRUITING | Detroit | Michigan | 48201 | United States | Details |
| Roswell Park Comprehensive Cancer Center | RECRUITING | Buffalo | New York | 14263 | United States | Details |
| Icahn School of Medicine at Mount Sinai | RECRUITING | New York | New York | 10029 | United States | Details |
| FirstHealth of the Carolinas | RECRUITING | Pinehurst | North Carolina | 28374 | United States | Details |